| Issue Date | Title | Author(s) |
| 2014-01-01 | An analytical framework for delirium research in palliative care settings: Integrated epidemiologic, clinician-researcher, and knowledge user perspectives | Lawlor, PG; Davis, DHJ; Ansari, M; Hosie, A; Kanji, S; Momoli, F; Bush, SH; Watanabe, S; Currow, DC; Gagnon, B; Agar, M; Bruera, E; Meagher, DJ; De Rooij, SEJA; Adamis, D; Caraceni, A; Marchington, K; Stewart, DJ |
| 2004-01-01 | A benchmark framework for risk management | Platen, E; Akahori, J; Ogawa, S; Watanabe, S |
| 2016-04-01 | Biotransformation of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans | Watanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S |
| 2016-11-01 | Channel Simulation and Coded Source Compression | Hsieh, MH; Watanabe, S |
| 2022-07-01 | Comparison between human liver microsomes and the fungus Cunninghamella elegans for biotransformation of the synthetic cannabinoid JWH-424 having a bromo-naphthyl moiety analysed by high-resolution mass spectrometry | Watanabe, S; Iwai, T; Matsushita, R; Nakanishi, T; Kuzhiumparambil, U; Fu, S; Seto, Y |
| 2016-04 | Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans | Watanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S |
| 2016-06-01 | Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans | Watanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S |
| 2015-12-17 | Fully quantum source compression with a quantum helper | Hsieh, MH; Watanabe, S |
| 2013-09-01 | Global flood risk under climate change | Hirabayashi, Y; Mahendran, R; Koirala, S; Konoshima, L; Yamazaki, D; Watanabe, S; Kim, H; Kanae, S |
| 2019-06 | Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis. | Pavasini, R; Serenelli, M; Celis-Morales, CA; Gray, SR; Izawa, KP; Watanabe, S; Colin-Ramirez, E; Castillo-Martínez, L; Izumiya, Y; Hanatani, S; Onoue, Y; Tsujita, K; Macdonald, PS; Jha, SR; Roger, VL; Manemann, SM; Sanchis, J; Ruiz, V; Bugani, G; Tonet, E; Ferrari, R; Volpato, S; Campo, G |
| 2017-07-01 | In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl | Watanabe, S; Vikingsson, S; Roman, M; Green, H; Kronstrand, R; Wohlfarth, A |
| 2018-07-01 | In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry | Watanabe, S; Kuzhiumparambil, U; Fu, S |
| 2017-07-01 | Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans | Watanabe, S; Kuzhiumparambil, U; Nguyen, MA; Cameron, J; Fu, S |
| 2021-01-01 | Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples | Leong, HS; Watanabe, S; Kuzhiumparambil, U; Fong, CY; Moy, HY; Yao, YJ; Witting, PK; Fu, S |
| 2015-03-01 | Oxidation of testosterone by permanganate and its implication in sports drug testing | Kuzhiumparambil, U; Watanabe, S; Fu, S |
| 2014-01-01 | Practical assessment of delirium in palliative care | Leonard, MM; Nekolaichuk, C; Meagher, DJ; Barnes, C; Gaudreau, JD; Watanabe, S; Agar, M; Bush, SH; Lawlor, PG |
| 2015-09-28 | Source compression with a quantum helper | Hsieh, MH; Watanabe, S |
| 2018-03-01 | Structural Elucidation of Metabolites of Synthetic Cannabinoid UR-144 by Cunninghamella elegans Using Nuclear Magnetic Resonance (NMR) Spectroscopy | Watanabe, S; Kuzhiumparambil, U; Fu, S |
